Загрузка...
Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy
PURPOSE: To prospectively compare the effects of half-dose verteporfin (3 mg/m(2)) photodynamic therapy (1/2 PDT) with those of one-third-dose verteporfin (2 mg/m(2)) PDT (1/3 PDT) for chronic central serous chorioretinopathy (CSC). METHODS: Sixteen eyes of 16 consecutive patients with chronic CSC w...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3351069/ https://ncbi.nlm.nih.gov/pubmed/22573069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2012.66 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|